From September, all adults aged 65-74 who are living with a chronic respiratory disease and those with immunosuppression due to disease or treatment will be offered the respiratory syncytial virus ...

Respiratory syncytial virus (RSV) has been a continuous and major cause of morbidity and mortality in babies and older people ...

The Food and Drug Administration on Wednesday approved the world’s first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making.

mResvia has been approved in the EU since 2024 to protect adults aged 60 years and older against lower respiratory tract ...

It’s that time of year when any cough or sniffle could be Covid-19, flu or RSV — but there are ways to fend them off. Forecasts from the US Centers for Disease Control and Prevention suggest that this ...

Understand RSV and how to stay protected. Respiratory syncytial virus (RSV) is a highly contagious condition that can cause serious illness. The good news? For most, a single dose is all it takes to ...

There are urgent calls for elderly Australians to get vaccinated for RSV, as more than one million remain unprotected.

The Deputy Director of the Directorate-General of Health (DGS) announced today that, starting in 2027, the vaccine against Respiratory Syncytial Virus (RSV) will reach all babies up to one year of age ...

Adults are more likely to experience severe infections from respiratory syncytial virus (RSV) if they have certain high-risk ...

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of ...

Pfizer Inc announced an update on their ongoing clinical study. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has entered a new arena in the investing world, powering the in ...